Answers are grounded in this paper and cite their sources.
Exploratory study shows association between PET parameters and disease progression in systemic sclerosis-related lung disease, indicating potential clinical utility.
This exploratory study showed that ⁶⁸Ga-FAPI-46 PET/CT imaging, specifically early volume-based PET parameters, was associated with patients with recent disease progression of SSc-ILD. Prospective validation in treatment-response studies is needed to confirm the clinical utility of these PET parameters and their identified preliminary thresholds.
No takes yet. Share an insight, caveat, or question.
Tai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: